Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Tenascin-N Inhibitors

Tenascin-N inhibitors are a specialized group of chemical compounds specifically designed to target and inhibit the function of Tenascin-N, a member of the tenascin family of extracellular matrix proteins. Tenascin-N is known for its involvement in various cellular processes, particularly those related to the structure and function of the extracellular matrix. The inhibitors in this class are characterized by their unique ability to interact with and modulate the activity of Tenascin-N, primarily through binding to specific sites on the protein. This interaction is crucial for the inhibitors' effectiveness, as it directly influences Tenascin-N's role in the extracellular matrix. The molecular structure of Tenascin-N inhibitors is typically complex and carefully designed to maximize binding affinity and specificity. These structures often include a variety of functional groups, which are strategically positioned to facilitate interactions with key domains of the Tenascin-N protein, such as those involved in binding to other extracellular matrix components or cell surface receptors.

The development of Tenascin-N inhibitors involves a combination of advanced chemical synthesis, molecular biology, and computational modeling techniques. Researchers in this field focus on understanding the precise molecular interactions between these inhibitors and Tenascin-N, employing a range of methodologies such as X-ray crystallography, NMR spectroscopy, and molecular docking studies. These techniques are pivotal in determining the optimal configuration of the inhibitors, ensuring that they effectively target Tenascin-N with high specificity. Furthermore, the physicochemical properties of Tenascin-N inhibitors, such as solubility, stability, and molecular weight, are critical considerations in their development. These properties are meticulously optimized to enhance the inhibitors' performance in terms of their interaction with Tenascin-N and their behavior in various environments. The intricate design of Tenascin-N inhibitors reflects the complexity of their target protein and the crucial role that precise molecular interactions play in achieving effective inhibition of Tenascin-N's function in the extracellular matrix.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$94.00
$208.00
19
(1)

Cyclopamine inhibits the Hedgehog signaling pathway, which may downregulate extracellular matrix protein genes like Tenascin-N.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$40.00
$120.00
$480.00
$2141.00
47
(3)

DAPT is a Notch pathway inhibitor that could potentially decrease Tenascin-N expression by altering cell differentiation signals.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Quercetin is known for its role in modulating various signaling pathways, which could include those regulating Tenascin-N transcription.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine affects lysosomal function and autophagy, which might impact cellular pathways and thereby reduce Tenascin-N expression.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic Acid influences cell differentiation and may alter the expression of extracellular matrix components, including Tenascin-N.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Cisplatin causes DNA damage which can influence transcriptional regulation, potentially decreasing Tenascin-N expression.

A 83-01

909910-43-6sc-203791
sc-203791A
10 mg
50 mg
$202.00
$811.00
16
(1)

A 83-01 is an inhibitor of TGF-β type I receptor ALK5, which might downregulate Tenascin-N expression through altered signaling.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib affects proteasome activity, potentially altering the stability of transcription factors regulating Tenascin-N expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine is a DNA methyltransferase inhibitor that can change the epigenetic state of genes, potentially affecting Tenascin-N expression.

LY 364947

396129-53-6sc-203122
sc-203122A
5 mg
10 mg
$107.00
$156.00
4
(1)

LY 364947 is a TGF-β receptor kinase inhibitor that might downregulate Tenascin-N expression by influencing TGF-β signaling.